WallStSmart

Intuitive Surgical Inc (ISRG)vsResMed Inc (RMD)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Intuitive Surgical Inc generates 105% more annual revenue ($11.58B vs $5.65B). RMD leads profitability with a 27.0% profit margin vs 25.5%. RMD appears more attractively valued with a PEG of 1.34. RMD earns a higher WallStSmart Score of 65/100 (C+).

ISRG

Buy

58

out of 100

Grade: C

Growth: 6.0Profit: 9.0Value: 5.3Quality: 7.8
Piotroski: 4/9Altman Z: 5.95

RMD

Buy

65

out of 100

Grade: C+

Growth: 6.0Profit: 9.0Value: 4.7Quality: 9.0
Piotroski: 5/9Altman Z: 4.52
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ISRGUndervalued (+78.3%)

Margin of Safety

+78.3%

Fair Value

$1989.68

Current Price

$436.87

$1552.81 discount

UndervaluedFair: $1989.68Overvalued
RMDSignificantly Overvalued (-21.2%)

Margin of Safety

-21.2%

Fair Value

$214.26

Current Price

$227.08

$12.82 premium

UndervaluedFair: $214.26Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ISRG6 strengths · Avg: 9.0/10
Operating MarginProfitability
33.3%10/10

Strong operational efficiency at 33.3%

Altman Z-ScoreHealth
5.9510/10

Safe zone — low bankruptcy risk

Market CapQuality
$152.62B9/10

Large-cap with strong market position

Profit MarginProfitability
25.5%9/10

Keeps 26 of every $100 in revenue as profit

Revenue GrowthGrowth
21.7%8/10

Revenue surging 21.7% year-over-year

Free Cash FlowQuality
$1.11B8/10

Generating 1.1B in free cash flow

RMD6 strengths · Avg: 9.2/10
Operating MarginProfitability
30.9%10/10

Strong operational efficiency at 30.9%

Altman Z-ScoreHealth
4.5210/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
23.1%9/10

Every $100 of equity generates 23 in profit

Profit MarginProfitability
27.0%9/10

Keeps 27 of every $100 in revenue as profit

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

Free Cash FlowQuality
$1.65B8/10

Generating 1.6B in free cash flow

Areas to Watch

ISRG4 concerns · Avg: 3.0/10
PEG RatioValuation
2.004/10

Expensive relative to growth rate

Price/BookValuation
9.5x4/10

Trading at 9.5x book value

P/E RatioValuation
52.2x2/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
-23.6%2/10

Earnings declined 23.6%

RMD1 concerns · Avg: 4.0/10
EPS GrowthGrowth
2.4%4/10

2.4% earnings growth

Comparative Analysis Report

WallStSmart Research

Bull Case : ISRG

The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 25.5% and operating margin at 33.3%. Revenue growth of 21.7% demonstrates continued momentum.

Bull Case : RMD

The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.0% and operating margin at 30.9%. PEG of 1.34 suggests the stock is reasonably priced for its growth.

Bear Case : ISRG

The primary concerns for ISRG are PEG Ratio, Price/Book, P/E Ratio. A P/E of 52.2x leaves little room for execution misses.

Bear Case : RMD

The primary concerns for RMD are EPS Growth.

Key Dynamics to Monitor

ISRG profiles as a growth stock while RMD is a mature play — different risk/reward profiles.

ISRG carries more volatility with a beta of 1.46 — expect wider price swings.

ISRG is growing revenue faster at 21.7% — sustainability is the question.

RMD generates stronger free cash flow (1.6B), providing more financial flexibility.

Bottom Line

RMD scores higher overall (65/100 vs 58/100), backed by strong 27.0% margins. ISRG offers better value entry with a 78.3% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Intuitive Surgical Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.

ResMed Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Visit Website →

Want to dig deeper into these stocks?